348 Stock Overview
An investment holding company, sells Chinese health products in Hong Kong and The People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
China Healthwise Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.053 |
| 52 Week High | HK$0.16 |
| 52 Week Low | HK$0.034 |
| Beta | 0.015 |
| 11 Month Change | -5.36% |
| 3 Month Change | -15.87% |
| 1 Year Change | -35.37% |
| 33 Year Change | -84.64% |
| 5 Year Change | -87.67% |
| Change since IPO | -98.61% |
Recent News & Updates
A Look At The Fair Value Of China Healthwise Holdings Limited (HKG:348)
Jul 26
China Healthwise Holdings Limited's (HKG:348) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
May 30Is China Healthwise Holdings (HKG:348) Using Debt In A Risky Way?
May 21China Healthwise Holdings Limited's (HKG:348) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors
Mar 28Recent updates
A Look At The Fair Value Of China Healthwise Holdings Limited (HKG:348)
Jul 26China Healthwise Holdings Limited's (HKG:348) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
May 30Is China Healthwise Holdings (HKG:348) Using Debt In A Risky Way?
May 21China Healthwise Holdings Limited's (HKG:348) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors
Mar 28China Healthwise Holdings (HKG:348) Is Making Moderate Use Of Debt
Dec 11More Unpleasant Surprises Could Be In Store For China Healthwise Holdings Limited's (HKG:348) Shares After Tumbling 26%
Jun 08China Healthwise Holdings Limited (HKG:348) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Jun 07Does China Healthwise Holdings (HKG:348) Have A Healthy Balance Sheet?
Mar 31China Healthwise Holdings (HKG:348) Is Carrying A Fair Bit Of Debt
Oct 10Is China Healthwise Holdings (HKG:348) Using Too Much Debt?
Dec 12China Healthwise Holdings (HKG:348) Has Debt But No Earnings; Should You Worry?
Aug 29Shareholder Returns
| 348 | HK Leisure | HK Market | |
|---|---|---|---|
| 7D | -10.2% | 3.4% | -1.9% |
| 1Y | -35.4% | -12.6% | -6.7% |
Return vs Industry: 348 underperformed the Hong Kong Leisure industry which returned -12.5% over the past year.
Return vs Market: 348 underperformed the Hong Kong Market which returned -5.5% over the past year.
Price Volatility
| 348 volatility | |
|---|---|
| 348 Average Weekly Movement | 25.1% |
| Leisure Industry Average Movement | 4.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in HK Market | 14.1% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 348's share price has been volatile over the past 3 months.
Volatility Over Time: 348's weekly volatility has increased from 19% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 100 | n/a | www.healthwisehk.com |
China Healthwise Holdings Limited, an investment holding company, sells Chinese health products in Hong Kong and The People’s Republic of China. The company operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. It sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers.
China Healthwise Holdings Limited Fundamentals Summary
| 348 fundamental statistics | |
|---|---|
| Market cap | HK$40.84m |
| Earnings (TTM) | -HK$134.56m |
| Revenue (TTM) | HK$146.32m |
0.3x
P/S Ratio-0.3x
P/E RatioIs 348 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 348 income statement (TTM) | |
|---|---|
| Revenue | HK$146.32m |
| Cost of Revenue | HK$193.49m |
| Gross Profit | -HK$47.17m |
| Other Expenses | HK$87.38m |
| Earnings | -HK$134.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | -32.24% |
| Net Profit Margin | -91.96% |
| Debt/Equity Ratio | 2,295.6% |
How did 348 perform over the long term?
See historical performance and comparison